Benitec Biopharma Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Benitec Biopharma Inc. reported Cash And Cash Equivalents At Carrying Value of $97.74 million for the year ending 2025.

  • Benitec Biopharma Inc. showed an increase of +92.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Benitec Biopharma Inc.'s annual report (Form 10-K), filed with the SEC on September 22, 2025.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), Benitec Biopharma Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 722.8%.
  • Historical annual values: Fiscal year 2025: $97.74 million | Fiscal year 2024: $50.87 million | Fiscal year 2023: $2.48 million | Fiscal year 2022: $4.06 million | Fiscal year 2021: $19.77 million | Fiscal year 2020: $9.80 million | Fiscal year 2019: $15.72 million | Fiscal year 2018: $11.88 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: